Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Genentech bags Lunsumio FDA approval for R/R follicular lymphoma Lunsumio FDA approval : Genentech, a subsidiary of the Roche Group, has secured the approval of the US… byRaghuram KadariDecember 28, 2022